Pharmaceuticals

Osteoarthritis Gene Therapy Market Size and Revenue Impact Study 2025 to 2034

Osteoarthritis Gene Therapy Market Size is valued at US$ 1.4 Bn in 2024 and is predicted to reach US$ 4.0 Bn by the year 2034 at an 11.7% CAGR during the forecast period for 2025 to 2034. Osteoarthritis Gene Therapy Market Size, Share & Trends Analysis Distribution by Therapeutic Approach (Gene Editing, Gene Delivery, Gene Regulation, Gene Silencing, Gene Replacement), by Type of Therapy (Autologous Therapy, Allogeneic Therapy), By Administr...

Report ID: 3223  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Central Fill Pharmacy Automation Market Forecast with Size and Share Analysis 2025 to 2034

Global Central Fill Pharmacy Automation Market Size is valued at US$ 0.6 Bn in 2024 and is predicted to reach US$ 1.5 Bn by the year 2034 at an 9.5% CAGR during the forecast period for 2025 to 2034. Central Fill Pharmacy Automation Market Size, Share & Trends Analysis Distribution By Type of Offering (Equipment (Automated Packaging and Labeling Systems, Integrated Workflow Automation Systems, Automated Tabletop Counters, Automated Medication...

Report ID: 3224  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Living Therapeutic Agents (LTA) Market Size, Share and Trends Report 2025 to 2034

Global Living Therapeutic Agents (LTA) Market Size is valued at US$ 116.5 Bn in 2024 and is predicted to reach US$ 364.8 Bn by the year 2034 at an 12.5% CAGR during the forecast period for 2025 to 2034. Living Therapeutic Agents (LTA) Market Size, Share & Trends Analysis Distribution by Type (Live Biotherapeutic Products, Cell-based Therapies, and Genetically Engineered Microbes), by Application (Gastrointestinal Disorders, Infectious Diseas...

Report ID: 3228  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

mRNA Synthesis and Manufacturing Services Market Size, Share and Growth Analysis 2025 to 2034

Global mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.52 Mn in 2024 and is predicted to reach USD 2,294.90 Mn by the year 2034 at a 7.7% CAGR during the forecast period for 2025 to 2034. In 2024 market has grown exponentially due to the success of the COVID-19 vaccines, and it has created a massive demand for a consistent supply of vaccines. However, in 2022 market is expected to decrease at the growth rate of -42.0%....

Report ID: 1185  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 270

Next-Generation ELISA (ELISA 2.0) Market Size, Share Detailed Report 2025 to 2034

Global Next-Generation ELISA (ELISA 2.0) Market Size is predicted to grow at a 9.6 % CAGR during the forecast period for 2025 to 2034. Next-Generation ELISA (ELISA 2.0) Market, Share & Trends Analysis Report, By Product Type (Kits & Reagents, Instruments & Analyzers, Software & Services), By Technology Platform (Detection Method, Advanced Formats),By Application (Biopharma & QC, Diagnostics, Research & Development, Others...

Report ID: 3241  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Peptide CDMO 2.0 Market Market Size and Scope 2025 to 2034

Global Peptide CDMO 2.0 Market Size is predicted to grow at a 12.9% CAGR during the forecast period for 2025 to 2034. Peptide CDMO 2.0 Market, Share & Trends Analysis Report, By Product Type / Modality (Linear Peptides, Cyclic Peptides, Stapled Peptides, Peptide–Drug Conjugates (PDCs), Peptide–Oligonucleotide Conjugates, GLP-1 and Related Long-Acting Analogues, Oral Peptide Formulations), By Scale of Operation (Preclinical, Clini...

Report ID: 3242  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Multi-Modal Spatial Omics Platforms Market Key Players Analysis 2025 to 2034

Global Multi-Modal Spatial Omics Platforms Market Size is valued at USD 174.23 Mn in 2024 and is predicted to reach USD 504.55Mn by the year 2034 at a 11.4% CAGR during the forecast period for 2025 to 2034. Multi-Modal Spatial Omics Platforms Market, Share & Trends Analysis Report, By Multi-Omic Combination (RNA + Protein, Protein + Metabolite/Lipid, RNA + DNA / Genomic features, Tri-modal (RNA + Protein + Morphology/Metabolite)), By Detecti...

Report ID: 3243  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Electronic Investigator Site File (eISF) Market Size, Share and Trends Analysis 2025 to 2034

Global Electronic Investigator Site File (eISF) Market Size is predicted to grow at a 14.6 % CAGR during the forecast period for 2025 to 2034. Electronic Investigator Site File (eISF) Market, Share & Trends Analysis Report, By Deployment Type (Cloud-Based, On-Premise), By End-User (Clinical Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Hospitals and Clinical Sites), By Applicat...

Report ID: 3244  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Psychedelic API Market Size, Share and Trends Analysis 2025 to 2034

Global Psychedelic API Market Size is valued at US$ 3.5 Bn in 2025 and is predicted to reach US$ 10.5 Bn by the year 2034 at an 12.8% CAGR during the forecast period for 2025 to 2034. Psychedelic API Market Size, Share & Trends Analysis Distribution By Molecule / Class (Psilocybin / Psilocin, MDMA, MDMA Base, MDMA Salts, Lysergide / LSD, Tryptamines, Iboga Alkaloids, Ketamine Class, Next-Gen 5-HT2A Modulators / Psychoplastogens), By Source /...

Report ID: 3329  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 180

Ultomiris Drug Market Current Trends Analysis 2025 to 2034

Global Ultomiris Drug Market Size is valued at USD 3.9 Bn in 2024 and is predicted to reach USD 44.3 Bn by the year 2034 at a 27.7% CAGR during the forecast period for 2025 to 2034. Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (PNH, Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder), By End Use, By Distribution Channel, By Region, And By Segment Forecasts, 2025 to 2034. Ultomiris (ravulizumab-cwvz) is c...

Report ID: 3113  |  

Delivery: Immediate  |  

Published: December 2025   |  

No. of Pages: 170